Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes

Area of Science:

• Endocrinology
• Developmental Biology
• Molecular Biology

Background:

• The islets of Langerhans contain diverse endocrine cell types, including alpha (glucagon), beta (insulin), delta (somatostatin), and PP (pancreatic polypeptide) cells.
• Understanding the ontogenic relationships and differentiation pathways of these cell types is crucial for comprehending pancreatic islet development and function.

Purpose of the Study:

• To investigate the ontogenic relationships between different endocrine cell types within the islets of Langerhans.
• To determine the necessity of glucagon, insulin, and pancreatic polypeptide-expressing cells for the differentiation of other islet endocrine cell types.

Main Methods:

• Generation of transgenic mouse embryos.
• Targeted destruction of specific endocrine cell populations using promoter-driven diphtheria toxin A chain expression (targeting glucagon, insulin, or pancreatic polypeptide genes).
• Analysis of islet cell composition and differentiation in genetically modified embryos.

Main Results:

• Embryos lacking glucagon- or insulin-expressing cells showed normal development of other islet endocrine cell types.
• Embryos lacking pancreatic polypeptide gene-expressing cells also lacked insulin- and somatostatin-containing cells.
• Glucagon and insulin cells are not essential for the differentiation of other islet endocrine cell types.

Conclusions:

• Pancreatic polypeptide-expressing cells are indispensable for the differentiation of islet beta (insulin) and delta (somatostatin) cells.
• This indispensability may be due to paracrine/endocrine factors or a direct cell-lineage relationship.
• The findings highlight a critical role for pancreatic polypeptide cells in islet development.